REGN

Regeneron Pharmaceuticals, Inc.
Pharmaceuticals

Cash & Equivalents

$3.12B
As of 2025-12-31
Current Price: $748.87 (as of 2026-04-12)

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $3.12B
Total Obligations: -$7.34B
$-4.22B
Per share: $-44.73
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $3.12B
AR: $5.74B
Total Obligations: -$7.34B
$1.52B
Per share: $16.08
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $3.12B
AR: $5.74B
Inventory: $3.20B
Total Obligations: -$7.34B
$4.72B
Per share: $49.98
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-4.22B$-44.73
Liquid Liquidation Value$1.52B$16.08
Operating Liquidation Value$4.72B$49.98

Key Components (as of 2025-12-31)

Cash & Equivalents$3.12B
Accounts Receivable$5.74B
Inventory$3.20B
Current Liabilities$4.37B
Long-term Debt$1.99B
Op. Lease Liability$266.80M
Finance Lease$720.00M
Shares OutstandingN/A

Explore all 207 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31 $3.12B $5.74B $3.20B $939.00M $4.37B $1.99B $266.80M $720.00M
2025-09-30 $2.51B $5.69B $3.25B $903.80M $4.43B $1.99B N/A $720.00M
2025-06-30 $2.00B $5.61B $3.21B $723.90M $3.67B $1.99B N/A $720.00M
2025-03-31 $3.09B $5.56B $3.19B $705.50M $3.57B $1.98B N/A $720.00M
2024-12-31 $2.49B $6.21B $3.09B $789.50M $3.94B $1.98B $234.40M $720.00M
2024-09-30 $2.01B $6.11B $3.02B $497.30M $3.66B $1.98B N/A $720.00M
2024-06-30 $1.92B $5.72B $2.87B $561.70M $3.51B $1.98B N/A $720.00M
2024-03-31 $2.60B $5.22B $2.71B $671.30M $3.58B $1.98B N/A $720.00M

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-04 View
2025-09-30 10-Q 2025-10-28 View
2025-06-30 10-Q 2025-08-01 View
2025-03-31 10-Q 2025-04-29 View
2024-12-31 10-K 2025-02-05 View
2024-09-30 10-Q 2024-10-31 View
2024-06-30 10-Q 2024-08-01 View
2024-03-31 10-Q 2024-05-02 View